To be honest, biotech stocks have always been one of the most difficult sectors to trade in my opinion: they are strongly driven by news, highly volatile, and subject to extreme sentiment.
A few months ago, a friend invited me to join a small discussion group. Members shared their daily insights on biotech stocks: stock selection logic (pipeline, catalysts, expectations vs. reality), key price ranges and potential failure points, risk warnings (experimentation phases, secondary offerings, overheated market sentiment). It wasn't a simple "bullish/bearish" approach, but rather a clear explanation of why they held those views. This gave me a clearer understanding of sector dynamics, news-driven speculation, and position sizing, saving me from many pitfalls.
What surprised me most was that this group is completely free. There are no courses sold, no paid signals, just a group of people who are seriously studying biotech exchanging ideas. If you also explore this field, you might understand: sometimes what improves isn't returns, but the quality of decision-making and survival rate.
Happy New Year and best wishes for successful trading!